RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cerevel Therapeutics Holdings Stock

Cerevel Therapeutics Holdings Equity 2024

Cerevel Therapeutics Holdings Equity

673.74 M USD

Ticker

CERE

ISIN

US15678U1280

WKN

A2QF3L

In 2024, Cerevel Therapeutics Holdings's equity was 673.74 M USD, a 29.27% increase from the 521.2 M USD equity in the previous year.

Cerevel Therapeutics Holdings Aktienanalyse

What does Cerevel Therapeutics Holdings do?

Cerevel Therapeutics Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Cerevel Therapeutics Holdings's Equity

Cerevel Therapeutics Holdings's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Cerevel Therapeutics Holdings's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Cerevel Therapeutics Holdings's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Cerevel Therapeutics Holdings's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Cerevel Therapeutics Holdings’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Cerevel Therapeutics Holdings stock

What is the equity of Cerevel Therapeutics Holdings this year?

Cerevel Therapeutics Holdings has equity of 673.74 M USD this year.

What was the equity of Cerevel Therapeutics Holdings compared to the previous year?

The equity of Cerevel Therapeutics Holdings has increased/decreased by 29.27% increased compared to the previous year.

What impact does a high equity have on investors of Cerevel Therapeutics Holdings?

A high equity is advantageous for investors of Cerevel Therapeutics Holdings as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Cerevel Therapeutics Holdings?

A low equity can be a risk for investors of Cerevel Therapeutics Holdings, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Cerevel Therapeutics Holdings affect the company?

An increase in equity of Cerevel Therapeutics Holdings can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Cerevel Therapeutics Holdings affect the company?

A reduction in equity of Cerevel Therapeutics Holdings can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Cerevel Therapeutics Holdings?

Some factors that can affect the equity of Cerevel Therapeutics Holdings include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Cerevel Therapeutics Holdings so important for investors?

The equity of Cerevel Therapeutics Holdings is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Cerevel Therapeutics Holdings take to change the equity?

To change equity, Cerevel Therapeutics Holdings can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Cerevel Therapeutics Holdings pay?

Over the past 12 months, Cerevel Therapeutics Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cerevel Therapeutics Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Cerevel Therapeutics Holdings?

The current dividend yield of Cerevel Therapeutics Holdings is .

When does Cerevel Therapeutics Holdings pay dividends?

Cerevel Therapeutics Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cerevel Therapeutics Holdings?

Cerevel Therapeutics Holdings paid dividends every year for the past 0 years.

What is the dividend of Cerevel Therapeutics Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cerevel Therapeutics Holdings located?

Cerevel Therapeutics Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cerevel Therapeutics Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cerevel Therapeutics Holdings from 8/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/24/2024.

When did Cerevel Therapeutics Holdings pay the last dividend?

The last dividend was paid out on 8/24/2024.

What was the dividend of Cerevel Therapeutics Holdings in the year 2023?

In the year 2023, Cerevel Therapeutics Holdings distributed 0 USD as dividends.

In which currency does Cerevel Therapeutics Holdings pay out the dividend?

The dividends of Cerevel Therapeutics Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cerevel Therapeutics Holdings

Our stock analysis for Cerevel Therapeutics Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cerevel Therapeutics Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.